A record $51.3 billion (£38.1bn) has been invested in global healthtech this year, up 280% on 2016 levels.
The COVID-19 pandemic has catalysed investment in an already growing healthtech sector, with new funding highs reached for companies using technology to improve research, delivery, payment and consumption of care.
The US leads globally with $31.9 billion (£23.7bn) in venture capital...
Helium Health acquires doctor booking platform Meddy Inc.
African health tech provider Helium Health has announced the acquisition of doctor booking platform, Meddy Inc., which has operations in Qatar and the UAE.
Helium, which is present in Nigeria, Ghana, Liberia, Senegal, Kenya, and Uganda, plans to deploy its electronic medical record (EMR) technology and healthcare financial solutions across...
Calling the U.S. healthcare system complex would be like calling the universe big: an understatement that poorly conveys its true scale. It's populated with primary care physicians, specialists, pharmacists, insurance companies, labs, therapists, caregivers and others – all using different tools, methods of communication and care delivery solutions.
Our healthcare system attempts to deliver...
A new report from Research2Guidance discusses the rise in digital decentralised clinical trial (DDCT) technologies since the COVID-19 pandemic.
Digital solutions for decentralised clinical trials allow some or all clinical trial activities to be conducted virtually rather than in person. This includes technology such as wearables to continuously collect patient data, telemedicine to deliver...
Adults in Scotland can now access Big Health’s digital therapeutics for anxiety and insomnia for free via the NHS.
People across all 14 NHS Scotland health board areas are able to self-refer or visit their GP to receive cognitive behavioural therapy (CBT) through the Daylight and Sleepio apps.
In October last year, the Scottish Government made the Big Health apps available across five NHS...
Healthcare software company Commure has raised around $500 million over two rounds of funding, according to reporting by Insider. Its sources say the company is now valued at $3.5 billion after the latest Series D round, which closed last week.
A spokesperson for Commure said the company doesn’t comment on funding or valuation.
Insider reported that Human Capital and Greenoaks Capital led the...
Sydney-based firms Synapse Medical Services, an automated clinical coding tool provider, and EBM Analytics, a clinical research consultant, have recently collaborated to integrate their technologies.
WHAT THEY DO
Aside from clinical coding, Synapse also offers a transcription service and an app-based online medical billing system. It also runs the healthcare training organisation, Australian...
Medical genetic testing company Invitae announced Tuesday it had signed a definitive agreement to acquire Ciitizen, a startup that helps users access and organize their health records, for about $325 million.
The terms of the deal include around $125 million in cash and approximately 7,070,000 shares of Invitae common stock. Invitae will also issue about $226 million restricted stock units to new...
Students over the age of 12 returning to school or university in Saudi Arabia this week are required to show proof of vaccination via the Kingdom’s COVID-19 tracing application, it has been announced.
According to the country’s Ministry of Education, students will only be granted access to school premises subject to being fully immunised against SARS-CoV-2. Vaccination status is available through...
Abu Dhabi’s Etihad Airways is extending its trial of a COVID-19 travel verification solution provided by the Singapore-based technology company, Affinidi, it has emerged.
Since March of this year, Affinidi has been working with the United Arab Emirates (UAE) airline, which has been utilising its Healthcare Network Assessment (HNA) programme on flights from Singapore to Abu Dhabi.
The trial has...
_28.jpg?itok=XgRdAaT4 "Global healthtech has received $51.3 billion in investment this year, marking new highs for venture capitalist interest in the sector and identifying London as the fastest growing healthtech hub globally.")
_5.JPG?itok=9t4-61cv)
